Work

Late Breaking Abstract - RPL554, a first-in-class dual PDE3/4 inhibitor, causes significant bronchodilation and symptom relief; a Phase 2b COPD study

Year: 2018

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2018.oa1940

Authors: Brian Maurer, Dave Singh, Fernando Martinez, Kenneth Newman

Institutions: Medicines Evaluation Unit, Weill Cornell Medicine

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2906336780

Cites:

Cited by: 1

Related to: 10